As of Jul 22
| +0.30 / +0.86%|
The 10 analysts offering 12-month price forecasts for Medicines Co have a median target of 49.00, with a high estimate of 65.00 and a low estimate of 43.00. The median estimate represents a +39.17% increase from the last price of 35.21.
The current consensus among 10 polled investment analysts is to Buy stock in Medicines Co. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.